Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

The Mutation Landscape of Follicular Lymphoma and Chronic Lymphocytic Leukemia Reveals a Distinctive Frequency and Composition of Aid-Related Mutation Signatures

Julieta Sepulveda, MSc, Cornelis A.M. van Bergen, PhD, Diego Alvarez, MSc, Szymon Kielbasa, PhD, Hailiang Mei, PhD, Hendrik Veelken, MD PhD, Marcelo Navarrete Signorile, MD PhD

Blood (2017) 130 (Supplement 1): 2741.

https://doi.org/10.1182/blood.V130.Suppl_1.2741.2741

Published: 2017

Journal Articles

Targeting DNA Repair Mechanisms to Overcome Drug Resistance in Diffuse Large B Cell Lymphoma

Julie Devin, Yea-Lih Lin, PhD, Alboukadel Kassambara, PhD, Guillaume Cartron, Olivier Elemento, PhD, Angelos Constantinou, PhD, Philippe Pasero, PhD, Caroline Bret, PhD PharmD, Jerome Moreaux, PhD

Blood (2017) 130 (Supplement 1): 1479.

https://doi.org/10.1182/blood.V130.Suppl_1.1479.1479

Published: 2017

Journal Articles

Phosphoramide Mustard (PM) Population Pharmacokinetics to Estimate Inter-Individual Variability in Exposure and Identify Clinical Factors Associated with Variability in Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplant (HCT) Patients

Kinjal Sanghavi, M Pharm, Anthony C. Wiseman, MD, Mark Kirstein, PharmD, Richard Brundage, PharmD PhD, Pamala A. Jacobson, PharmD

Blood (2014) 124 (21): 2478.

https://doi.org/10.1182/blood.V124.21.2478.2478

Published: 2014

Journal Articles

Clinical Efficacy of Mitoxantrone-Based Salvage Chemotherapy in Adult Patients with Relapsed or Refractory All; Retrospective Multicenter Study of Korean Adult ALL Working Party

Jae-Sook Ahn, MD, PhD, Deok-Hwan Yang, MD, PhD, Sung-Hoon Jung, MD, Je-Jung Lee, MD, PhD, Inho Kim, MD, PhD, Seonyang Park, MD, PhD, Joo-Seop Jung, Ho-Jin Shin, Dae-Young Kim, Kyoo-Hyung Lee, Joon Ho Moon, MD, Sang Kyun Sohn, MD, Ik-Chan Song, Deog Yeon Jo

Blood (2012) 120 (21): 4306.

https://doi.org/10.1182/blood.V120.21.4306.4306

Published: 2012

Journal Articles

Mesodermal Development From Reprogrammed Fanconi Anemia Cells Is Affected by ALDH2 Enzymatic Activity

Naoya Suzuki, MS, Asuka Hira, MD, Akira Niwa, MD, PhD, Megumu Saito, MD, PhD, Keitaro Matsuo, MD, PhD, Tatsutoshi Nakahata, MD, PhD, Minoru Takata, MD, PhD, Miharu Yabe, MD, PhD

Blood (2012) 120 (21): 648.

https://doi.org/10.1182/blood.V120.21.648.648

Published: 2012

Journal Articles

CPOP-R Versus CHOP-R As First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Phase 2, Randomized, Open-Label, Multicenter Study

Raoul Herbrecht, David MacDonald, MD, FRCPC, Florian Weissinger, MD, Martin Wilhelm, MD, Charles Holladay, MS, MD, Nam H. Dang, MD, PhD, Peter Holman, MD, Paul Cernohous, MS, Jack Singer, MD, Richard H. van der Jagt, MD, FRCPC

Blood (2011) 118 (21): 1605.

https://doi.org/10.1182/blood.V118.21.1605.1605

Published: 2011

Journal Articles

Phase 3 Trial of Pixantrone Dimaleate Compared with Other Agents as Third-Line, Single-Agent Treatment of Relapsed Aggressive Non-Hodgkin Lymphoma (EXTEND): End of Study Results.

Ruth Pettengell, FRACP, PhD, Pier Luigi Zinzani, MD, PhD, Geetha Narayanan, MD, Fernando Hurtado de Mendoza, MD, Raghunadharao Digumarti, MD, Henry Gomez, MD, Bertrand Coiffier, MD, PhD, Gary Schiller, MD, David A. Rizzieri, MD, Paul Cernohous, MS, Lixia Wang, PhD, Jack Singer, MD

Blood (2010) 116 (21): 2833.

https://doi.org/10.1182/blood.V116.21.2833.2833

Published: 2010

Journal Articles

A Polymerase Chain Reaction-Based Method to Detect Gene-Specific Adducts Induced by Anticancer Drugs. Clinical Application in Multiple Myeloma.

Meletios A. Dimopoulos, Christine Liakos, Hara G. Episkopou, Dimitra T. Stefanou, Soterios A. Kyrtopoulos, Petros P. Sfikakis, Evangelos Terpos, Aristotelis Bamias, Vassilis L. Souliotis

Blood (2009) 114 (22): 1879.

https://doi.org/10.1182/blood.V114.22.1879.1879

Published: 2009

Journal Articles

Melphalan-Induced DNA Damage In Vitro as Predictor for Clinical Outcome in Multiple Myeloma.

Meletios A. Dimopoulos, MD, Vassilis L. Souliotis, PhD, Athanasios Anagnostopoulos, M.D., Christina Bamia, PhD, Anastasia Pouli, M.D., Ioannis Baltadakis, M.D., Evangelos Terpos, M.D., Soterios A. Kyrtopoulos, PhD, Petros P. Sfikakis, M.D.

Blood (2006) 108 (11): 60.

https://doi.org/10.1182/blood.V108.11.60.60

Published: 2006

Journal Articles

The Ellipticine Derivative NSC 338258 Has Anti-Myeloma Activity.

Erming Tian, BS, Owen Stephens, BS, Susan Holbeck, PhD, Bart Barlogie, MD, PhD, John Shaughnessy, Jr., PhD

Blood (2005) 106 (11): 3379.

https://doi.org/10.1182/blood.V106.11.3379.3379

Published: 2005

Journal Articles

Measurement of Individual p53-Specific Damage Formation and Repair Following In Vitro Exposure of Peripheral Mononuclear Cells to Melphalan May Predict Clinical Outcome in Patients with Multiple Myeloma (MM) Subsequently Treated with High Dose Melphalan (HDM) and Autologous Blood Stem Cell Transplantation (ASCT).

Meletios A. Dimopoulos, MD, V. L. Souliotis, PhD, A. Anagnostopoulos, MD, A. Pouli, MD, I. Baltadakis, MD, E. Terpos, MD, Petros P. Sfikakis, MD

Blood (2005) 106 (11): 1167.

https://doi.org/10.1182/blood.V106.11.1167.1167

Published: 2005

NARROW

The Mutation Landscape of Follicular Lymphoma and Chronic Lymphocytic Leukemia Reveals a Distinctive Frequency and Composition of Aid-Related Mutation Signatures

Targeting DNA Repair Mechanisms to Overcome Drug Resistance in Diffuse Large B Cell Lymphoma

Phosphoramide Mustard (PM) Population Pharmacokinetics to Estimate Inter-Individual Variability in Exposure and Identify Clinical Factors Associated with Variability in Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplant (HCT) Patients

Clinical Efficacy of Mitoxantrone-Based Salvage Chemotherapy in Adult Patients with Relapsed or Refractory All; Retrospective Multicenter Study of Korean Adult ALL Working Party

Mesodermal Development From Reprogrammed Fanconi Anemia Cells Is Affected by ALDH2 Enzymatic Activity

CPOP-R Versus CHOP-R As First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Phase 2, Randomized, Open-Label, Multicenter Study

Phase 3 Trial of Pixantrone Dimaleate Compared with Other Agents as Third-Line, Single-Agent Treatment of Relapsed Aggressive Non-Hodgkin Lymphoma (EXTEND): End of Study Results.

A Polymerase Chain Reaction-Based Method to Detect Gene-Specific Adducts Induced by Anticancer Drugs. Clinical Application in Multiple Myeloma.

Melphalan-Induced DNA Damage In Vitro as Predictor for Clinical Outcome in Multiple Myeloma.

The Ellipticine Derivative NSC 338258 Has Anti-Myeloma Activity.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only